Association of levels of inflammatory markers (Interleukin 6, serum ferritin and high-sensitivity C-reactive protein) with severity of illness in patients with Covid-19.
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/07/034664
- Lead Sponsor
- Maulana Azad Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Patients with Covid-19 Positive status diagnosed by either RT-PCR or Rapid Antigen Test Kit.
Exclusion Criteria
1. Patients on prior history of immunosuppressive therapy.
2. Patients already started on steroid / Tocilizumab or any other novel immunosuppressive
therapy after admission .
3. Patients who already received convalescent plasma therapy.
4. Patients with Pregnancy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To estimate the association of inflammatory markers (interleukin 6 ,serum ferritin and high sensitivity c-reactive protein) levels with severity of illness in patients with covid-19.Timepoint: Less than or equals to 9 months
- Secondary Outcome Measures
Name Time Method To estimate the association of inflammatory markers (interleukin 6 ,serum ferritin and high sensitivity c-reactive protein) levels with severity of illness in patients with covid-19.Timepoint: Less than or equals to 9 months